<div id="readability-page-1"><div>Dubai, United Arab Emirates, “Fast heart rate while resting?” That is the question at the centre of a new awareness initiative launched by Merck, a leading science and technology company, to mark World Hypertension Day. The campaign aims to encourage greater understanding of elevated resting heart rate as a potential signal within the broader cardiovascular risk conversation.As part of the initiative, Merck has launched a new Hypertension Risk Checker designed to encourage earlier awareness and proactive heart health management.According to the World Health Organization, 1.4 billion people (around one in three adults worldwide) live with high blood pressure, while an estimated 600 million adults remain unaware that they have the condition.Across the Gulf region, cardiovascular disease continues to represent a growing health challenge, reinforcing the importance of awareness, early detection, and proactive heart health management.Often referred to as the “silent killer,” hypertension can develop without noticeable symptoms1, leaving many individuals unaware they may be at risk until serious health complications arise. Elevated resting heart rate may feel like a rapid, racing, or pounding heartbeat2, even when a person is not physically active, and may serve as an important signal to seek medical advice.Ahmed Abo Al Fadl, General Manager – UAE &amp; Gulf, Merck said: “Hypertension continues to be one of the most significant yet underdiagnosed health challenges globally and across our region. Through greater awareness, earlier conversations, and accessible educational tools such as the Hypertension Risk Checker, we hope to encourage more people to take proactive steps towards understanding and managing their heart health.”This year also marks four decades of Merck’s legacy in cardiovascular care, reflecting the company’s longstanding commitment to supporting patients living with cardiovascular conditions through science, innovation, and quality healthcare solutions.For four decades, Merck’s cardiovascular portfolio has supported the treatment journey of more than 535,000 patients across the Gulf region.World Hypertension Day is observed annually to encourage individuals to take simple but important steps toward better heart health, including checking blood pressure regularly, maintaining healthy lifestyle habits, and consulting healthcare professionals when needed.To access the free Hypertension Risk Checker tool, please visit: https://www.cardioriskchecker.com/About MerckMerck, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck generated sales of € 21.2 billion in 65 countries.Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.Send us your press releases to pressrelease.zawya@lseg.comDisclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.</div></div>

Merck has launched a Hypertension Risk Checker to raise awareness about elevated resting heart rates as a potential cardiovascular risk, coinciding with World Hypertension Day. The initiative aims to encourage proactive heart health management, addressing the fact that 1.4 billion people globally live with high blood pressure, many unaware of their condition. Merck emphasizes the importance of early detection and education in managing heart health, marking four decades of commitment to cardiovascular care in the Gulf region.

ZAWYA: Merck marks World Hypertension Day with launch of Hypertension Risk Checker